Susavion Bioscience is a biotechnology company formed to advance technology based on discovery of multi-valent, bio-active peptides that mimic carbohydrate ligands of lectin-type receptors suitable for use as therapeutic modulators of the immune system. It develops a pipeline of proprietary product candidates directed to a range of cancer indications by expanding an active innate immune system.